D-0575-2025 Class II Ongoing

Recalled by Pfizer — Manhattan, NY

FDA drug recall D-0575-2025 was initiated by Pfizer on Jul 29, 2025 and is designated Class II. Reason for recall: Subpotent drug The recall status is ongoing. Affected quantity: 29, 004 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 20, 2025
Initiation Date
Jul 29, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
29, 004 bottles

Product description

Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.

Reason for recall

Subpotent drug

Distribution pattern

Within U.S

Code information

Lot #: 24C11, Exp 2/28/2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0575-2025
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Pfizer? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0575-2025. Report a data issue: hello@regdatalab.com.